Matthew Perrone

Read the latest stories and analysis from Matthew Perrone.

FILE - In this file photo made June 30, 2010 three Avandia pills are displayed near the bottle in Palo Alto, Calif. The Food and Drug Administration said Monday, Nov. 25, 2013, it is lifting severe safety restrictions on the former blockbuster diabetes pill Avandia, citing recent data suggesting that the much-debated medication does not increase the risk of heart attack. (AP Photo/Paul Sakuma, File)

FDA overturns safety limits on diabetes drug

Matthew Perrone · November 25, 2013 9:55 pm

FDA tells 23andMe to halt sales of genetic test

Matthew Perrone · November 25, 2013 8:19 pm

Drug sales to hit lowest growth rate in decades

Matthew Perrone · November 19, 2013 3:06 pm

Bulk mixers of prescribed drugs get more scrutiny

Matthew Perrone · November 18, 2013 11:45 pm

Sen. David Vitter, R-La., walks to the Senate at the Capitol in Washington, Tuesday, Nov. 12, 2013. Vitter cast the lone vote in opposition to a bill designed to tighten government oversight of pharmacies that custom-mix prescription drugs, a measure to make lawmakers disclose which of their aides are enrolling in the president's new health care program as part of an ongoing effort to discredit "Obamacare." (AP Photo/J. Scott Applewhite)

Senate votes to advance specialty pharmacy bill

Associated Press, Matthew Perrone · November 13, 2013 12:41 am

Health overhaul debate snags Senate pharmacy bill

Matthew Perrone · November 11, 2013 10:19 pm

FDA enlists companies to head off drug shortages

Matthew Perrone · October 31, 2013 6:16 pm

FDA approves more powerful, pure hydrocodone drug

Matthew Perrone · October 25, 2013 9:32 pm

FDA panel backs Gilead Sciences’ hepatitis C drug

Matthew Perrone · October 25, 2013 8:46 pm

FILE - In this Feb. 19, 2013 file photo, hydrocodone bitartrate and acetaminophen pills, also known as Vicodin, are arranged for a photo at a pharmacy in Montpelier, Vt. The Food and Drug Administration on Thursday, Oct. 24, 2013 recommended new restrictions on prescription medicines containing hydrocodone, the highly addictive painkiller that has grown into the most widely prescribed drug in the U.S. (AP Photo/Toby Talbot, File)

FDA wants limits on most prescribed painkillers

Matthew Perrone · October 25, 2013 12:03 am

Companies offer health benefits to transgender workers

Matthew Perrone · October 24, 2013 3:52 pm

The Food and Drug Administration holds a public meeting this week to review two experimental medications from Johnson & Johnson and Gilead Sciences. The new drugs, if approved, could offer a quicker, more effective approach to eliminating hepatitis C, a blood-borne disease blamed for 15,000 deaths in the U.S. this year. (Photo: Thinkstock)

FDA reviews 2 promising new drugs for hepatitis C

Associated Press, Matthew Perrone · October 22, 2013 4:00 am